Enliven Therapeutics

ELVN

Enliven Therapeutics has been a target of short sellers for a while. The current short interest of 12.74% is slightly above the average of the last 12 months (10.47%).

Short Interest Trend

Share Price

Total NSP

12.74%

-1.39%

vs. last month

Also interesting? All insider buys at Enliven Therapeutics

Found an error? Questions? Ideas?